Showing results (61-70 of 424) with videos related to

Sort By:
Pageof 43
Journal of Hepatology|January 5, 2023
Rational combination therapy for NASH: Insights from clinical trials and errorVlad Ratziu, Michael Charlton
La Revue Du Praticien|February 22, 2013
[Epidemiology and natural history of nonalcoholic fatty liver disease]Raluca Pais, Vlad Ratziu
Clinical Chemistry|June 12, 2004
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis CThierry Poynard, Mona Munteanu, Françoise Imbert-Bismut, et al.
Plos One|December 5, 2008
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markersThierry Poynard, Patrick Ingiliz, Laure Elkrief, et al.
Clinical Chemistry|August 26, 2006
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis CYen Ngo, Mona Munteanu, Djamila Messous, et al.
Biomedicines|March 25, 2022
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2011
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)Helmi M'Kada, Mona Munteanu, Hugo Perazzo, et al.
Clinics in Liver Disease|October 13, 2009
Pharmacologic therapy of non-alcoholic steatohepatitisVlad Ratziu, Shira Zelber-Sagi
Journal of Hepatology|July 23, 2003
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis BRobert P Myers, Marie Hélène Tainturier, Vlad Ratziu, et al.
Gastroenterology|May 28, 2008
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) TrialVlad Ratziu, Philippe Giral, Sophie Jacqueminet, et al.
Pageof 43